Skip to Main content

Keywords

Researcher identifiers

Export Publications

Export the displayed publications:
Number of documents

59

CV Izabela Jelovac HAL


Journal articles13 documents

  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. Health Economics, Wiley, In press, ⟨10.1002/hec.4113⟩. ⟨halshs-02910863⟩
  • Izabela Jelovac, Samuel Nzale. Regulation and altruism. Journal of Public Economic Theory, Wiley, 2020, 22 (1), pp.49-68. ⟨10.1111/jpet.12368⟩. ⟨halshs-01618043⟩
  • Nicolas Houy, Izabela Jelovac. Comparing approval procedures for new drugs. The World Economy, Wiley, 2019, 42 (5), pp. 1598-1619. ⟨10.1111/twec.12746⟩. ⟨halshs-01937219⟩
  • Carine Franc, Izabela Jelovac. Des « Nobels » de sciences économiques au service des systèmes de santé. médecine/sciences, EDP Sciences, 2018, 34 (3), pp. 261-266. ⟨halshs-01819380⟩
  • Izabela Jelovac, Philippe Polomé. Incentives to patients versus incentives to health care providers: The users' perspective. Health Economics, Wiley, 2017, 26 (12), pp. e319-e331. ⟨halshs-01524174⟩
  • Izabela Jelovac. Physicians’ balance billing, supplemental insurance and access to health care. International Journal of Health Economics and Management, Springer, 2015, 15 (2), pp. 269-280. ⟨halshs-01231376⟩
  • Izabela Jelovac. On the relationship between the negociated price of pharmaceuticals and the patients' co-payment. Economics Bulletin, Economics Bulletin, 2015, 35 (1), 14 p. ⟨halshs-01089720⟩
  • Nicolas Houy, Izabela Jelovac. Drug launch timing and international reference pricing. Health Economics, Wiley, 2015, 24 (8), pp. 978-989. ⟨halshs-00993816⟩
  • Izabela Jelovac, Frieda Vandeninden. How should donors give foreign aid ? A theoretical comparison of aid modalities. European Journal of Development Research, Palgrave Macmillan, 2014, 26, pp. 886-904. ⟨10.1057/ejdr.2014.14⟩. ⟨halshs-00968789⟩
  • Marie Allard, Izabela Jelovac, Pierre-Thomas Léger. Payment mechanism and GP self-selection: capitation versus fee for service. International Journal of Health Care Finance and Economics, Springer Verlag, 2014, 14 (2), pp. 143-160. ⟨10.1007/s10754-014-9143-z⟩. ⟨halshs-00968734⟩
  • Marie Allard, Izabela Jelovac, Pierre-Thomas Léger. Treatment and referral decisions under different physician payment mechanisms. Journal of Health Economics, Elsevier, 2011, 30 (5), pp. 880-893. ⟨halshs-00650933⟩
  • Begoña Garcia Mariñoso, Izabela Jelovac, Pau Olivella. External referencing and pharmaceutical price negotiation. Health Economics, Wiley, 2011, 20 (6), pp. 737-756. ⟨10.1002/hec.1630⟩. ⟨halshs-00303682⟩
  • Khalid Habbani, Wim Groot, Izabela Jelovac. Do free-of-charge public health services impede cost recovery policies in Khartoum state, Sudan?. Eastern Mediterranean health journal = La revue de santé de la Méditerranée orientale, 2007, 13 (4), pp. 939-952. ⟨halshs-00257536⟩

Conference papers40 documents

  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. Chaire Hospinnomics (PSE et AP-HP), Mar 2019, Paris, France. ⟨halshs-02148454⟩
  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. Public Economic Theory Conference, Jul 2019, Strasbourg, France. ⟨halshs-02409758⟩
  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. EARIE Conference, Aug 2019, Barcelone, Spain. ⟨halshs-02409768⟩
  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. Bureau d'Economie Théorique et Appliquée (BETA), Mar 2019, Strasbourg, France. ⟨halshs-02148462⟩
  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. 37ème Tax Day du Max Planck Institute for Tax Law and Public Finance, Nov 2019, Munich, Germany. ⟨halshs-02409743⟩
  • Francesca Barigozzi, Izabela Jelovac. Basic, applied research, and price negotiation for new drugs. Séminaire, Universität Augsburg, Jun 2018, Augsburg, Germany. ⟨halshs-01947857⟩
  • Izabela Jelovac. Enjeux tarifaires de la médecine génomique. . Workshop EcoGen 2018, Université de Bourgogne, Oct 2018, Dijon, France. ⟨halshs-01947866⟩
  • Izabela Jelovac, Nicolas Houy. Drug approval decision times, international reference pricing and strategic launches of new drugs. Séminaire Hospinnomics. Paris School of Economics et Assistance Publique - Hôpitaux de Paris, Jun 2017, Paris, France. ⟨halshs-01657274⟩
  • Izabela Jelovac. Health services: Incentives and access. Deutsche Gesellschaft für Gesundheitsökonomie e.V. Workshop, Hamburg Center for Health Economics, Universität Hamburg, Nov 2017, Hambourg, Germany. ⟨halshs-01762837⟩
  • Izabela Jelovac. Health Services: Incentives and Access. Keynote speech. Workshop on Allocation and Distribution. German Association of Health Economics, Nov 2017, Hamburg, Germany. ⟨halshs-01657111⟩
  • Izabela Jelovac, Samuel Kembou Nzale. Healthcare providers’ payments with personalized medicine. PET (Public Economic Theory) 2016 conference, Jul 2016, Rio de Janeiro, Brazil. ⟨halshs-01447580⟩
  • Izabela Jelovac. Médecine personnalisée et prix des médicaments. Ateliers de réflexion sur des enjeux contemporains en santé, Université de Lyon ; Fondation pour l'Université de Lyon, Programme Avenir Lyon-St Etienne, Mérieux Université, Institut de Recherches Philosophiques de Lyon, Mar 2016, Lyon, France. ⟨halshs-01327046⟩
  • Izabela Jelovac, Nicolas Houy. Drug approval decision times, international reference pricing and access to new drugs. 38èmes Journées des Economistes de la Santé Français (JESF), Dec 2016, Lyon, France. ⟨halshs-01447164⟩
  • Izabela Jelovac. Personalized medicine and drug prices. Workshop Théorie microéconomique appliquée, Mar 2016, Ecully, France. ⟨halshs-01327069⟩
  • Izabela Jelovac. Drug approval decision times, international reference pricing and strategic launches of new drugs. Séminaire, Université Pablo de Olavide, Apr 2015, Séville, Spain. ⟨halshs-01178630⟩
  • Izabela Jelovac. La Médecine personnalisée. JECO 2015, Organisation et animation de la Table Ronde sur la Médecine personnalisée, Oct 2015, Lyon, France. ⟨halshs-01231709⟩
  • Izabela Jelovac, Nicolas Houy. Drug approval decision times, international reference pricing and strategic launches of new drugs. Séminaire AMSE-GREQUAM, Nov 2015, Marseille, France. ⟨halshs-01261578⟩
  • Izabela Jelovac, Philippe Polomé. Demand versus Supply Side Cost-Sharing: Patients’ preferences. Séminaire à l'Université de Bourgogne, Jan 2015, Dijon, France. ⟨halshs-01179409⟩
  • Izabela Jelovac. Drug approval decision times, international reference pricing and strategic launches of new drugs. European Workshop on Health Economics, Toulouse School of Economics, May 2015, Toulouse, France. ⟨halshs-01178636⟩
  • Izabela Jelovac, Philippe Polomé. Incentives to patients versus incentives to health care providers: The users' perspective. XXXe Jornadas de Economia Industrial, Sep 2015, Alicante, Spain. ⟨halshs-01232476⟩
  • Izabela Jelovac. Drug approval decision times, international reference pricing and strategic launches of new drugs. Workshop on Health Economics, Universidad Autonoma de Barcelona, Apr 2015, Barcelone, Spain. ⟨halshs-01178631⟩
  • Izabela Jelovac, Nicolas Houy. Drug launch timing and international reference pricing. XXIXe Jornadas de Economia Industrial, Barcelona Graduate School of Economics, Invited Session on Health Economics, Sep 2014, Barcelone, France. ⟨halshs-01088164⟩
  • Izabela Jelovac, Philippe Polomé. Demand versus Supply Side Cost-Sharing: The users' perspective. Séminaire à l’Université de Vigo, May 2014, Vigo, Spain. ⟨halshs-01096307⟩
  • Nicolas Houy, Izabela Jelovac. Drug launch timing and international reference pricing. 63ème congrès de l'AFSE, 16-18 juin 2014, Jun 2014, Lyon, France. ⟨halshs-01096276⟩
  • Izabela Jelovac, Philippe Polomé. Demand versus Supply Side Cost-Sharing: The users' perspective. 2014 PhDSeminar on Health Economics and Policy, Grindelwald, Suisse, 26- 30 janvier 2014, Jan 2014, Grindelwald, Switzerland. ⟨halshs-00955843⟩
  • Izabela Jelovac. Drug approval decision times, international reference pricing and strategic launches of new drugs. Séminaire à l'Université de Hambourg, 8 décembre 2014, Dec 2014, Hambourg, Germany. ⟨halshs-01138229⟩
  • Izabela Jelovac, Philippe Polomé. Perception du lien entre mode de rémunération et comportement des médecins. colloque "Vulnérabilités sanitaires et sociales" organisé par l'ANR, Paris, 14-15 novembre 2013, Nov 2013, Paris, France. ⟨halshs-00955849⟩
  • Nicolas Houy, Izabela Jelovac. Drug launch timing and international reference pricing. 2013 PhDSeminar on Health Economics and Policy, Grindelwald, Suisse, 27-30 janvier 2013, Jan 2013, Grindelwald, Switzerland. ⟨halshs-00955848⟩
  • Nicolas Houy, Izabela Jelovac. Drug launch timing and international reference pricing. 14th European Health Economics Workshop, Ecully, 24-25 mai 2013, May 2013, Ecully, France. ⟨halshs-00861222⟩
  • Izabela Jelovac. External Reference Pricing and Sequential Launching of Drugs. University of Kent School of Economics, Canterbury, 24 octobre 2012, Oct 2012, Canterbury, United Kingdom. ⟨halshs-00762205⟩
  • Izabela Jelovac. Physicians Balance Billing, Supplemental Insurance and Access to Health Care. 2012 PhDSeminar on Health Economics and Policy, Grindelwald, Suisse, 29 janvier - 1er février 2012, Jan 2012, Grindelwald, Switzerland. ⟨halshs-00683016⟩
  • Izabela Jelovac, Philippe Polomé. Preferences for Demand versus Supply Side Cost-Sharing. 13th European Health Economics Workshop, Séville, 25-26 mai 2012, May 2012, Séville, Spain. ⟨halshs-00735677⟩
  • Izabela Jelovac, Philippe Polomé. Perception du lien entre mode de rémunération et comportement des médecins. Conférence - Des solutions pour accroître la productivité dans le secteur public : l'exemple des services de soins de santé, HEC Montréal, Montréal, Canada, 3 octobre 2011, Oct 2011, Montréal, Canada. ⟨halshs-00673790⟩
  • Izabela Jelovac. Physicians Balance Billing, Supplemental Insurance and Access to Health Care. Workshop IDEA 20, Barcelone, 11 juin 2011, Jun 2011, Barcelone, Spain. ⟨halshs-00673815⟩
  • Izabela Jelovac. Physicians Balance Billing, Supplemental Insurance and Access to Health Care. European Health Economics Workshops (EHEW 12), Brescia, 18-19 mars 2011, Mar 2011, Brescia, Italy. ⟨halshs-00673814⟩
  • Izabela Jelovac. Physicians Balance Billing, Supplemental Insurance and Access to Health Care. 38th annuel Conference of the European Association for Research in Industrial Economics (EARIE), Stockholm, Suède, 1er - 3 septembre 2011, Sep 2011, Stockholm, Sweden. ⟨halshs-00673813⟩
  • Izabela Jelovac. Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance. 32èmes Journées des Économistes de la Santé Français (JESF), Lyon, France, 2-3 décembre 2010, Dec 2010, Lyon, France. ⟨halshs-00588706⟩
  • Izabela Jelovac. Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance. 8th European Conference on Health Economics, Helsinki, Finlande, 7-10 juillet 2010, Jul 2010, Helsinki, Finland. ⟨halshs-00588705⟩
  • Izabela Jelovac. On the relationship between the negociated price of pharmaceuticals and the patients' co-payment. Séminaire GAEL, Grenoble, 24 juin 2010, Jun 2010, Grenoble, France. ⟨halshs-00588703⟩
  • Izabela Jelovac. Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance. 1st Annual SEBA-GATE Workshop, Beijing Normal University, May 2010, Pékin, China. ⟨halshs-00492834⟩

Preprints, Working Papers, ...6 documents

  • Francesca Barigozzi, Izabela Jelovac. Research funding and price negotiation for new drugs. 2019. ⟨halshs-01987643⟩
  • Izabela Jelovac, Samuel Kembou Nzale. Regulation and Altruism. 2017. ⟨halshs-01616193⟩
  • Izabela Jelovac, Philippe Polomé. Incentives to patients versus incentives to health care providers: The users' perspective. 2015. ⟨halshs-01142578⟩
  • Nicolas Houy, Izabela Jelovac. Drug approval decision times, international reference pricing and strategic launches of new drugs. 2014. ⟨halshs-01072741⟩
  • Izabela Jelovac. Physicians' balance billing, supplemental insurance and access to health care. 2013. ⟨halshs-00787602⟩
  • Nicolas Houy, Izabela Jelovac. Drug launch timing and international reference pricing. 2013. ⟨halshs-00782179⟩